Methionine enkephalin (MENK) improved the functions of bone marrow-derived dendritic cells (BMDCs) loaded with antigen

References

• Marcotte I, Dufourc EJ, Ouellet M, Auger M. Interaction of the neuropeptide met-enkephalin with zwitterionic and negatively charged bicelles as viewed by 31P and 2H solid-state NMR. Biophys J 2003; 85:328 - 39; http://dx.doi.org/10.1016/S0006-3495(03)74477-4; PMID: 12829487
   PubMed Web of Science ®Google Scholar
• Plotnikoff GA. Spirituality, religion, and the physician: new ethical challenges in patient care. Bioethics Forum 1997; 13:25 - 30; PMID: 11660476
   PubMedGoogle Scholar
• Shan F, Xia Y, Wang N, Meng J, Lu C, Meng Y, et al. Functional modulation of the pathway between dendritic cells (DCs) and CD4+T cells by the neuropeptide: methionine enkephalin (MENK). Peptides 2011; 32:929 - 37; http://dx.doi.org/10.1016/j.peptides.2011.01.033; PMID: 21335041
   PubMed Web of Science ®Google Scholar
• McLaughlin PJ, Stack BC Jr., Braine KM, Ruda JD, Zagon IS. Opioid growth factor inhibition of a human squamous cell carcinoma of the head and neck in nude mice: dependency on the route of administration. Int J Oncol 2004; 24:227 - 32; PMID: 14654962
   PubMed Web of Science ®Google Scholar
• Zagon IS, McLaughlin PJ. Opioids and differentiation in human cancer cells. Neuropeptides 2005; 39:495 - 505; http://dx.doi.org/10.1016/j.npep.2005.07.001; PMID: 16169076
   PubMed Web of Science ®Google Scholar
• Blüml S, Zupkovitz G, Kirchberger S, Seyerl M, Bochkov VN, Stuhlmeier K, et al. Epigenetic regulation of dendritic cell differentiation and function by oxidized phospholipids. Blood 2009; 114:5481 - 9; http://dx.doi.org/10.1182/blood-2008-11-191429; PMID: 19864645
   PubMed Web of Science ®Google Scholar
• Khayrullina T, Yen JH, Jing H, Ganea D. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J Immunol 2008; 181:721 - 35; PMID: 18566439
   PubMed Web of Science ®Google Scholar
• Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005; 5:296 - 306; http://dx.doi.org/10.1038/nri1592; PMID: 15803149
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245 - 52; http://dx.doi.org/10.1038/32588; PMID: 9521319
   PubMed Web of Science ®Google Scholar
• Shimizu K, Kuriyama H, Kjaergaard J, Lee W, Tanaka H, Shu S. Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy. J Immunother 2004; 27:265 - 72; http://dx.doi.org/10.1097/00002371-200407000-00002; PMID: 15235387
   PubMed Web of Science ®Google Scholar
• Liu J, Chen W, Meng J, Lu C, Wang E, Shan F. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK). Cancer Immunol Immunother 2012; PMID: 22392190
   PubMed Web of Science ®Google Scholar
• Suen JL, Wu CH, Chen YY, Wu WM, Chiang BL. Characterization of self-T-cell response and antigenic determinants of U1A protein with bone marrow-derived dendritic cells in NZB x NZW F1 mice. Immunology 2001; 103:301 - 9; http://dx.doi.org/10.1046/j.1365-2567.2001.01255.x; PMID: 11454059
   PubMed Web of Science ®Google Scholar
• Dubsky P, Ueno H, Piqueras B, Connolly J, Banchereau J, Palucka AK. Human dendritic cell subsets for vaccination. J Clin Immunol 2005; 25:551 - 72; http://dx.doi.org/10.1007/s10875-005-8216-7; PMID: 16380819
   PubMed Web of Science ®Google Scholar
• Fry TJ, Shand JL, Milliron M, Tasian SK, Mackall CL. Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches. Cancer Immunol Immunother 2009; 58:1257 - 64; http://dx.doi.org/10.1007/s00262-008-0638-7; PMID: 19139888
   PubMed Web of Science ®Google Scholar
• Nowak AK, Lake RA, Marzo AL, Scott B, Heath WR, Collins EJ, et al. Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J Immunol 2003; 170:4905 - 13; PMID: 12734333
   PubMed Web of Science ®Google Scholar
• Osada T, Clay TM, Woo CY, Morse MA, Lyerly HK. Dendritic cell-based immunotherapy. Int Rev Immunol 2006; 25:377 - 413; http://dx.doi.org/10.1080/08830180600992456; PMID: 17169781
   PubMed Web of Science ®Google Scholar
• Van Nuffel AM, Benteyn D, Wilgenhof S, Pierret L, Corthals J, Heirman C, et al. Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients. Mol Ther 2012; 20:1063 - 74; http://dx.doi.org/10.1038/mt.2012.11; PMID: 22371843
   PubMed Web of Science ®Google Scholar
• Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000; 191:411 - 6; http://dx.doi.org/10.1084/jem.191.3.411; PMID: 10662786
   PubMed Web of Science ®Google Scholar
• Ferguson TA, Stuart PM, Herndon JM, Griffith TS. Apoptosis, tolerance, and regulatory T cells--old wine, new wineskins. Immunol Rev 2003; 193:111 - 23; http://dx.doi.org/10.1034/j.1600-065X.2003.00042.x; PMID: 12752676
   PubMed Web of Science ®Google Scholar
• Gilboa E. DC-based cancer vaccines. J Clin Invest 2007; 117:1195 - 203; http://dx.doi.org/10.1172/JCI31205; PMID: 17476349
   PubMed Web of Science ®Google Scholar
• Sharp BM. Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav Immun 2006; 20:9 - 14; http://dx.doi.org/10.1016/j.bbi.2005.02.002; PMID: 16364815
   PubMed Web of Science ®Google Scholar
• Kraus J. Regulation of mu-opioid receptors by cytokines. [Schol Ed] Front Biosci (Schol Ed) 2009; 1:164 - 70; PMID: 19482692
   PubMedGoogle Scholar
• Goel C, Govindaraj D, Singh BP, Farooque A, Kalra N, Arora N. Serine protease Per a 10 from Periplaneta americana bias dendritic cells towards type 2 by upregulating CD86 and low IL-12 secretions. Clin Exp Allergy 2012; 42:412 - 22; http://dx.doi.org/10.1111/j.1365-2222.2011.03937.x; PMID: 22356142
   PubMed Web of Science ®Google Scholar
• Li Y, van den Pol AN. Mu-opioid receptor-mediated depression of the hypothalamic hypocretin/orexin arousal system. J Neurosci 2008; 28:2814 - 9; http://dx.doi.org/10.1523/JNEUROSCI.5447-07.2008; PMID: 18337411
   PubMed Web of Science ®Google Scholar
• Marotti T, Haberstok H. Naloxone is an inappropriate antagonist of met-enkephalin-modulated superoxide anion release. Brain Behav Immun 1992; 6:223 - 33; http://dx.doi.org/10.1016/0889-1591(92)90045-P; PMID: 1327300
   PubMed Web of Science ®Google Scholar
• Gabrilovac J, Marotti T. Gender-related differences in murine T- and B-lymphocyte proliferative ability in response to in vivo [Met(5)]enkephalin administration. Eur J Pharmacol 2000; 392:101 - 8; http://dx.doi.org/10.1016/S0014-2999(00)00118-7; PMID: 10748278
   PubMed Web of Science ®Google Scholar
• Lichtman AH. T cell costimulatory and coinhibitory pathways in vascular inflammatory diseases. Front Physiol 2012; 3:18; http://dx.doi.org/10.3389/fphys.2012.00018; PMID: 22355289
   PubMedGoogle Scholar
• Xu X, Stockhammer F, Schmitt A, Casalegno-Garduno R, Enders A, Mani J, et al. Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells. Int J Oncol 2012; 40:764 - 72; PMID: 22134728
   PubMed Web of Science ®Google Scholar
• Cirone M, Lucania G, Aleandri S, Borgia G, Trivedi P, Cuomo L, et al. Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma cells. Immunol Lett 2008; 120:37 - 41; http://dx.doi.org/10.1016/j.imlet.2008.06.011; PMID: 18680763
   PubMed Web of Science ®Google Scholar
• Wang JC, Kobie JJ, Zhang L, Cochran M, Mosmann TR, Ritchlin CT, et al. An 11-color flow cytometric assay for identifying, phenotyping, and assessing endocytic ability of peripheral blood dendritic cell subsets in a single platform. J Immunol Methods 2009; 341:106 - 16; http://dx.doi.org/10.1016/j.jim.2008.11.002; PMID: 19049809
   PubMed Web of Science ®Google Scholar